You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SAR-COV-2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-term Effects of COVID-19

Recruiting
  • COVID-19
  • SAR-CoV-2
  • (R)-1-(2-chlorophenyl)- N-[11C] ([11C] PK11195)
  • 2-(4-[11C]methylamino phenyl)-6-hydroxybenzothiazole (11C]6-OH-BTA-1 or [11C]PIB)
  • Jacksonville, Florida
    Mayo Clinic Florida
May 31, 2022

Health in Penetrating Trauma Injuries Before and During COVID-19

Completed
  • Penetrating Injury
  • +2 more
  • Postive SAR-CoV-2 PCR nasopharyngeal swab
  • Bakersfield, California
    Kern Medical Center
Nov 15, 2023

Epidemiologic, Clinical and Molecular Characteristics of Acute

Recruiting
  • Covid19
  • Patient with SAR-CoV-2 infection
  • Rozzano, Milan, Italy
    Humanitas Research Hospital
Oct 17, 2022

COVID-19, SAR Trial in Hanover (CBDRA60 supplement, Placebo)

Not yet recruiting
  • COVID-19
  • SAR
  • CBDRA60 supplement
  • Placebo
  • Hanover, Michigan
    Anewsha Therapeutics / Comco R&D
Feb 18, 2022

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2

Recruiting
  • Covid19
  • Serologic immunoassays to SARS-CoV-2 antibodies
  • Detroit, Michigan
    Henry Ford Health System
Dec 13, 2022

SARS-CoV-2 Infection Trial in Malaysia, Philippines (Azvudine, Placebo)

Recruiting
  • SARS-CoV-2 Infection
  • Kuala Lumpur, Malaysia
  • +9 more
Jan 5, 2023

SARS CoV 2 Infection, SARS-CoV-2 Acute Respiratory Disease Trial in Bangkok (Human IgG1 anti-SARS-CoV-2 antibody cocktail,

Completed
  • SARS CoV 2 Infection
  • SARS-CoV-2 Acute Respiratory Disease
  • Human IgG1 anti-SARS-CoV-2 antibody cocktail
  • Placebo
  • Bangkok, Thailand
    National Cancer Institute of Thailand
Jul 5, 2022

Rheumatic Diseases Trial in Ciudad Autónoma de Buenos Aires, Buenos Aires (COVID-19 Vaccine)

Recruiting
  • Rheumatic Diseases
  • COVID-19 Vaccine
  • Ciudad Autónoma de Buenos Aires, Caba, Argentina
  • +1 more
Jan 30, 2023

Molecular Point-of-care Xpert® Xpress SARS-CoV-2 Detection

Not yet recruiting
  • Screening of Patients With Symptoms Suggestive of SARS-CoV-2 Infection
  • Gene Expert molecular Point-of-Care (POC) (Xpert® Xpress SARS-CoV-2/Flu/RSV test
  • (no location specified)
Aug 23, 2022

COVID-19 Pandemic Trial in Mae Sot (STANDARD Q COVID-19 Ag Test)

Active, not recruiting
  • COVID-19 Pandemic
  • STANDARD Q COVID-19 Ag Test
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit
Dec 5, 2022

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV-2 Virus Trial in Bangkok (SARS-CoV-2 RNA detection)

Completed
  • SARS-CoV-2 Virus
  • SARS-CoV-2 RNA detection
  • Bangkok, Thailand
    2 Division of Nephrology,Department of Medicine Pramongkutklao H
Aug 31, 2023

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023

Differential Leucocyte Count and Covid-19 Diagnosis

Withdrawn
  • SARS-CoV-2 Infection Covid19
  • Differential Leucocyte Count (CLDC) device and algorithm
  • Pozzilli, IS, Italy
    IRCCS INM Neuromed, Department of Epidemiology and Prevention
Jan 11, 2022

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • Saline
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)

Recruiting
  • SARS-CoV2 Infection
  • General SARS-CoV-2 Communication
  • Rural-Targeted SARS-CoV-2 Communication
  • Flint, Michigan
    Flint Journal Building
Oct 10, 2023

SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA vaccine (RBMRNA)
  • CoronaVac®
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

Asymptomatic SARS-CoV-2 Detection in Children

Completed
  • Covid19
  • SARS-CoV-2
    • Birmingham, Alabama
    • +4 more
    Nov 1, 2022

    COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))

    Not yet recruiting
    • COVID-19
    • NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
    • Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
    • (no location specified)
    Aug 4, 2023

    SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)

    Not yet recruiting
    • SARS-CoV-2 Infection
    • +2 more
    • eBAM Cov Testing
    • Marseille, France
    • +1 more
    Oct 23, 2023

    LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B

    Not yet recruiting
    • SARS-CoV-2
    • +4 more
    • LumiraDx SARS-CoV-2 Ag Ultra
    • LumiraDx SARS-CoV-2 & Flu A/B
    • DeLand, Florida
      Hillcrest Medical Research
    Feb 6, 2023

    SARS-CoV-2 Vaccination on Cancer Patients Infected With

    Recruiting
    • COVID-19 Infection
    • COVID-19 Vaccine
    • no intervention
    • Beijing, Beijing, China
      Sanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
    Mar 7, 2023

    SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)

    Recruiting
    • SARS-CoV-2
    • SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
    • 0.9% sodium chloride solution
    • Islamabad, Pakistan
      Sindh Infectious Diseases Hospital & Research Center Dow Univers
    Apr 16, 2023

    COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

    Recruiting
    • COVID-19
    • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
    • Guangzhou, Guangzhou, China
      The Fifth Affiliated Hospital of Guangzhou Medical University
    Jan 28, 2023

    COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)

    Not yet recruiting
    • COVID-19 Vaccine
    • COVID-19
    • 50 μg Baiya SARS-CoV-2 Vax 2
    • Placebo
    • Bangkok, Thailand
      Queen Saovabha Memorial Institute
    May 23, 2023